Immune evasion before tumour invasion in early lung squamous carcinogenesis-Reference-Cited by-同舟云学术

Immune evasion before tumour invasion in early lung squamous carcinogenesis

Published:2019-06-26 Issue:7766 Volume:571 Page:570-575
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Mascaux Céline,Angelova Mihaela,Vasaturo Angela,Beane Jennifer,Hijazi Kahkeshan,Anthoine Geraldine,Buttard Bénédicte,Rothe Françoise,Willard-Gallo Karen,Haller Annick,Ninane Vincent,Burny Arsène,Sculier Jean-Paul,Spira Avi,Galon Jérôme

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-1330-0.pdf

Reference30 articles.

1. Goldberg, S. W., Mulshine, J. L., Hagstrom, D. & Pyenson, B. S. An actuarial approach to comparing early stage and late stage lung cancer mortality and survival. Popul. Health Manag. 13, 33–46 (2010).

2. Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782–795 (2013).

3. Mlecnik, B. et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J. Clin. Oncol. 29, 610–618 (2011).

4. Herbst, R. S., Morgensztern, D. & Boshoff, C. The biology and management of non-small cell lung cancer. Nature 553, 446–454 (2018).

5. De Koning, H., Van Der Aalst, C., Ten Haaf, K. & Oudkerk, M. PL02.05 effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial. J. Thorac. Oncol. 13, S185 (2018).

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance;Molecular Cancer;2024-09-06

2. Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non–Small Cell Lung Cancer. An Official American Thoracic Society Research Statement;American Journal of Respiratory and Critical Care Medicine;2024-09-01

3. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy;Molecular Cancer;2024-08-26

4. Single-cell transcriptome profiles the heterogeneity of tumor cells and microenvironments for different pathological endometrial cancer and identifies specific sensitive drugs;Cell Death & Disease;2024-08-07

5. Advancing non-small cell lung cancer treatment: the power of combination immunotherapies;Frontiers in Immunology;2024-07-02